Medication Assisted Treatment (MAT) standards
Resources
Implementation of the MAT standards progress map
A map is available that shows the progress of Alcohol and Drug Partnerships (ADPs) in Scotland to meet the MAT standards.
Experiences of MAT standard implementation
This short video provides three perspectives on the Medication Assisted Treatment (MAT) standards.
These perspectives include:
- a person with lived experience of substance use
- a family member
- a member of staff working in a service
The video accompanies the 2024 MAT benchmarking report.
The video brings to life the experiences of some people involved in the MAT standards work. It does not represent the views, or experiences, of all people.
We thank those who supported this video on MAT standards and to all willing to share their time and views.
Rapid evidence review of integrated models of drug treatment in primary care
A report is available describing the ways of working to strengthen drugs treatment and support within primary care.
This is related to the MAT standard 7.
Access the rapid evidence review.
Evidence review on transitions of care
This rapid review provides a summary of the evidence on models of service provision, care and support to reduce the risk of drug-related harm among adults at known points of transition between services.
National benchmarking report on the implementation of MAT standards
Benchmarking reports are available about the progress that Alcohol and Drug Partnerships (ADPs) in Scotland are making to meet the medication assisted treatment (MAT) standards.
The reports include recommended actions to address gaps
The reports also include an infographic about the progress of MAT standards 1, 2, 3, 5 and 9 in Scotland.
View the national benchmarking reports.
MAT standards informed response to Benzodiazepine harm reduction guidance
This guidance aims to set out key principles which align with the MAT standards.
It is designed for all staff supporting those who present with high risks of drug-related harms.
Learn more about the MAT standards informed response to Benxodiazepine harm reduction.